"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 5 | 0 | 5 |
| 1999 | 9 | 2 | 11 |
| 2000 | 8 | 1 | 9 |
| 2001 | 3 | 0 | 3 |
| 2002 | 6 | 0 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 4 | 2 | 6 |
| 2005 | 4 | 0 | 4 |
| 2006 | 8 | 0 | 8 |
| 2007 | 4 | 0 | 4 |
| 2008 | 5 | 1 | 6 |
| 2009 | 10 | 2 | 12 |
| 2010 | 13 | 1 | 14 |
| 2011 | 11 | 5 | 16 |
| 2012 | 10 | 0 | 10 |
| 2013 | 8 | 0 | 8 |
| 2014 | 13 | 0 | 13 |
| 2015 | 10 | 0 | 10 |
| 2016 | 9 | 2 | 11 |
| 2017 | 8 | 1 | 9 |
| 2018 | 11 | 1 | 12 |
| 2019 | 3 | 0 | 3 |
| 2020 | 12 | 2 | 14 |
| 2021 | 12 | 1 | 13 |
| 2022 | 9 | 0 | 9 |
| 2023 | 8 | 0 | 8 |
| 2024 | 7 | 1 | 8 |
| 2025 | 6 | 1 | 7 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Repeat Influenza Vaccination Effects in 2021/22 and 2022/23 in a Community-Based Cohort in Hong Kong. J Infect Dis. 2026 Jun 16; 233(6):e1364-e1373.
-
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines. J Virol. 2026 Jun 23; 100(6):e0031726.
-
Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history. Nat Commun. 2026 May 11; 17(1).
-
Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine. J Nanobiotechnology. 2026 Mar 30; 24(1).
-
Recommended Vaccines for Immunocompetent Older Adults: A Work Group Report of the AAAAI Asthma, Allergic & Immunologic Diseases in Older Adults Committee. J Allergy Clin Immunol Pract. 2026 04; 14(4):791-801.
-
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination. EMBO Mol Med. 2026 04; 18(4):1456-1477.
-
Immune Priming and the Risk of COVID-19, Influenza, and Other Acute Respiratory Infections: Insights From an N3C Cohort. Influenza Other Respir Viruses. 2026 Mar; 20(3):e70253.
-
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial. J Infect Dis. 2025 Dec 20; 232(6):1319-1329.
-
Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation. PLoS Comput Biol. 2025 11; 21(11):e1013720.
-
Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays. Vaccine. 2026 Jan 01; 69:127956.